OrbusNeich CE marks Sapphire II balloon catheter
This article was originally published in Clinica
Executive Summary
OrbusNeich has CE marked its Sapphire II coronary dilatation balloon catheter for sale in Europe. The Hong Kong firm will immediately launch the device, designed to treat tight and complex lesions. The ultra-low profile Sapphire II may be used in a range of configurations, including 1.0mm diameter balloons and 150cm shaft versions.
You may also be interested in...
ITF Has A Fight On Its Hands In Duchenne
The group’s new muscular dystrophy pill seems unlikely to cut into Sarepta’s sales.
AbbVie Needs To Freshen Up
With half of its 2023 sales coming from aging blockbusters like Humira and Botox, AbbVie needs new blood.
AstraZeneca Pays $2bn To Keep Up With The Joneses
Bristol Myers Squibb and Lilly have recently done billion-dollar radiopharmaceuticals deals, and now the UK group wants a piece of the market. But can it make its Fusion fusion work?